Anthropic's IPO roadshow can start today and shares could list next week under the ticker ANT — can a regular investor actually buy in at the IPO price?
Anthropic filed its S-1 on October 26 and the amended filing on November 2 still leaves the price range and share count blank. Reports point to a roadshow starting this week and pricing in the week of November 16, with the stock listing on Nasdaq as ANT. The filing names Schwab, Fidelity, Robinhood, Trade-PMR, SoFi and E*TRADE as channels for individual investors to buy at the offering price. I have a Fidelity account and I am trying to figure out whether that actually gets me IPO-price shares, or whether the retail slice is so small that it is effectively institutions only. Has anyone here actually gotten IPO-price allocation through one of these brokers before, and what did it take?
1 answer
- Wait for the first trade
The filing is the checkable part: as of the November 2 amendment there is no price range, no share count and no date, so nothing can be bought yet. The roadshow can legally start November 10 because the S-1 went public October 26, fifteen days earlier. Retail access through the six named brokers is real, but the filing does not say how big the retail slice is, and in a deal this size institutions get most of it. Practical move: check whether your broker runs an IPO-access program and what it requires, then decide if you want ANT on day one or after the first-week volatility settles.